BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29127665)

  • 21. Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway--a population-based cohort study.
    Eskesen AN; Bjøro K; Aandahl EM; Line PD; Melum E
    Cancer Epidemiol; 2014 Dec; 38(6):741-7. PubMed ID: 25454262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients.
    Nam JY; Lee JH; Kim HY; Kim JE; Lee DH; Chang Y; Cho H; Yoo JJ; Lee M; Cho YY; Cho Y; Cho E; Yu SJ; Kim YJ; Yoon JH
    PLoS One; 2017; 12(1):e0166188. PubMed ID: 28099520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation.
    Liu W; Zheng Y; Zou R; Shen J; He W; Yang Z; Zhang Y; Li B; Yuan Y
    BMC Cancer; 2018 Nov; 18(1):1186. PubMed ID: 30497418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening and surveillance for hepatocellular carcinoma: perspective of a new era?
    Maida M; Malizia G; Affronti A; Virdone R; Maida C; Margherita V; D'amico G
    Expert Rev Anticancer Ther; 2016 Dec; 16(12):1291-1302. PubMed ID: 27730841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome and safety of targeted liver biopsies for indeterminate lesions in patients with chronic liver disease: A single centre experience.
    Chen X; Kutaiba N; Ngo B; Goodwin M
    J Med Imaging Radiat Oncol; 2019 Apr; 63(2):190-196. PubMed ID: 30652433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
    Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study.
    Borzio M; Fornari F; De Sio I; Andriulli A; Terracciano F; Parisi G; Francica G; Salvagnini M; Marignani M; Salmi A; Farinati F; Carella A; Pedicino C; Dionigi E; Fanigliulo L; Cazzaniga M; Ginanni B; Sacco R;
    Future Oncol; 2013 Feb; 9(2):283-94. PubMed ID: 23414477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical benefits of hepatocellular carcinoma surveillance: a single-center, hospital-based study.
    Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Motoyoshi Y; Shibata H; Eguchi K
    Oncol Rep; 2005 Oct; 14(4):999-1003. PubMed ID: 16142364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
    Thein HH; Campitelli MA; Yeung LT; Zaheen A; Yoshida EM; Earle CC
    PLoS One; 2015; 10(9):e0138907. PubMed ID: 26398404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Hepatocellular Carcinoma Surveillance in an Urban Population With Liver Cirrhosis.
    Nusbaum JD; Smirniotopoulos J; Wright HC; Dash C; Parpia T; Shechtel J; Chang Y; Loffredo C; Shetty K
    J Clin Gastroenterol; 2015; 49(10):e91-5. PubMed ID: 25751372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
    Wong LL; Reyes RJ; Kwee SA; Hernandez BY; Kalathil SC; Tsai NC
    Clin Mol Hepatol; 2017 Sep; 23(3):239-248. PubMed ID: 28706177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography -- a randomised study.
    Pocha C; Dieperink E; McMaken KA; Knott A; Thuras P; Ho SB
    Aliment Pharmacol Ther; 2013 Aug; 38(3):303-12. PubMed ID: 23750991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival.
    Trevisani F; Cantarini MC; Labate AM; De Notariis S; Rapaccini G; Farinati F; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M;
    Am J Gastroenterol; 2004 Aug; 99(8):1470-6. PubMed ID: 15307862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are hepatocellular carcinoma surveillance programs effective at improving the therapeutic options.
    Zapata E; Zubiaurre L; Castiella A; Salvador P; García-Bengoechea M; Esandi P; Arriola A; Beguiristain A; Ruiz I; Garmendia G; Orcolaga R; Alustiza JM
    Rev Esp Enferm Dig; 2010 Jul; 102(8):484-8. PubMed ID: 20670069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nurse-led hepatocellular carcinoma surveillance clinic provides an effective method of monitoring patients with cirrhosis.
    Nazareth S; Leembruggen N; Tuma R; Chen SL; Rao S; Kontorinis N; Cheng W
    Int J Nurs Pract; 2016 Jun; 22 Suppl 2():3-11. PubMed ID: 27476494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community.
    Wang JH; Chang KC; Kee KM; Chen PF; Yen YH; Tseng PL; Kuo YH; Tsai MC; Hung CH; Chen CH; Tai WC; Tsai LS; Chen SC; Lin SC; Lu SN
    Am J Gastroenterol; 2013 Mar; 108(3):416-24. PubMed ID: 23318478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B.
    Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD
    J Viral Hepat; 2015 Sep; 22(9):727-36. PubMed ID: 25581816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance for hepatocellular carcinoma.
    Sherman M
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):783-93. PubMed ID: 25260308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.
    Sersté T; Barrau V; Ozenne V; Vullierme MP; Bedossa P; Farges O; Valla DC; Vilgrain V; Paradis V; Degos F
    Hepatology; 2012 Mar; 55(3):800-6. PubMed ID: 22006503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.
    Atiq O; Tiro J; Yopp AC; Muffler A; Marrero JA; Parikh ND; Murphy C; McCallister K; Singal AG
    Hepatology; 2017 Apr; 65(4):1196-1205. PubMed ID: 27775821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.